2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Prostatic Neoplasms
138
Breast Neoplasms
95
Neoplasms
8
Neoplasm Metastasis
6
Breast Neoplasms, Male
6
Advanced Breast Cancer
4
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Osteoporosis
2
Leiomyoma
2
Infertility
2
Advanced Prostate Cancer
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Radiation Injuries
1
Primary Ovarian Insufficiency
1
Primary Dysautonomias
1
Patients With T1-4 Advanced Prostate Cancer
1
Patient Compliance
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Osteitis Deformans
1
Myofibroma
1
Lymphatic Metastasis
1
Kidney Diseases
1
Inflammatory Breast Neoplasms
1
Interventions
pembrolizumab
163
Carboplatin
146
Paclitaxel
125
Cyclophosphamide
94
130-nm albumin-bound paclitaxel
66
Capecitabine
64
Gemcitabine
54
Doxorubicin
50
Albumin-Bound Paclitaxel
45
Taxes
42
atezolizumab
41
Cisplatin
39
sacituzumab govitecan
34
Nivolumab
34
olaparib
32
Epirubicin
32
Specimen Handling
28
Docetaxel
28
eribulin
27
Bevacizumab
26
durvalumab
25
Drug Therapy
25
Biopsy
24
camrelizumab
23
Magnetic Resonance Spectroscopy
22
toripalimab
19
Radiotherapy
17
spartalizumab
16
Everolimus
15
veliparib
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Goserelin
×
Clear all
NCT05582499
2026-05-28
FASCINATE-N
Fudan University
Phase 2
Recruiting
716 enrolled
NCT03444025
2018-02-23
NeoGONT
Kasr El Aini Hospital
Phase 2
Unknown
180 enrolled